3,4-dihydroxyphenylacetic acid has been researched along with carnosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Berezhnoy, DS; Fedorova, TN; Kulikova, OI; Lopachev, AV; Orlova, VS; Stvolinsky, SL | 1 |
| Anderson, EJ; Builta, ZJ; Doorn, JA; Monroe, TB; Nelson, MM | 1 |
| Anderson, EJ; Crawford, RA; Doorn, JA; Gilardoni, E; Monroe, TB; Regazzoni, L | 1 |
3 other study(ies) available for 3,4-dihydroxyphenylacetic acid and carnosine
| Article | Year |
|---|---|
Neuroprotective effect of the carnosine - α-lipoic acid nanomicellar complex in a model of early-stage Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Brain; Carnosine; Dopamine; Homovanillic Acid; Male; Micelles; Nanoparticles; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Rats, Wistar; Serotonin; Thioctic Acid | 2018 |
Biochemical characterization of the catecholaldehyde reactivity of L-carnosine and its therapeutic potential in human myocardium.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aldehydes; Carnosine; Catechols; Cysteine; Glutathione; Humans; Middle Aged; Mitochondria; Myocardium; Oxidation-Reduction | 2019 |
Characterization of Catecholaldehyde Adducts with Carnosine and l-Cysteine Reveals Their Potential as Biomarkers of Catecholaminergic Stress.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Carnosine; Catechols; Cell Line, Tumor; Cysteine; Humans; Mice; Mice, Inbred C57BL; Molecular Structure; Monoamine Oxidase | 2021 |